Zobrazeno 1 - 10
of 31
pro vyhledávání: '"J M Delâge"'
Publikováno v:
Journal of Clinical Investigation. 60:1061-1069
The serum of a 44-yr-old woman of French-Canadian descent having a B-27 positive ankylosing spondylitis was deficient in the seventh component of complement (C7) as determined by hemolytic and immunochemical methods. No inhibitor against C7 was detec
Publikováno v:
British Journal of Cancer
BDF1 mice were inoculated with 10(6) leukaemic cells and, together with control mice, were given a single oral dose of cyclophosphamide-14C of 100 mg/kg body weight. In the leukaemic mice we observed an increased 14C concentration in the plasma, bone
Autor:
A, De Gramont, C, Louvet, M, Krulik, N, Smadja, D, Donadio, J P, Laporte, P, Brissaud, M, Smith, J M, Delâge, Y, Drolet
Publikováno v:
Cancer. 58(3)
Peripheral blood changes preceding therapy-related leukemia were studied in 105 patients who had received cytotoxic therapy, 53 for Hodgkin's disease and 52 for other cancers. Preleukemic anomalies were observed in 74.3% of the cases, appearing after
Publikováno v:
L'union medicale du Canada. 117(2)
Autor:
A, de Gramont, M, Bergeron, Y, Drolet, P, Leblond, E, Rioux, L, Desjardins, M, Gyger, P, d'Auteuil, J M, Delâge
Publikováno v:
L'union medicale du Canada. 114(4)
Autor:
J M, Delâge
Publikováno v:
L'union medicale du Canada. 108(2)
Publikováno v:
L'union medicale du Canada. 114(4)
Publikováno v:
L'union medicale du Canada. 103(1)
Autor:
A, de Gramont, C, Louvet, M, Krulik, N, Smadja, D, Donadio, J P, Laporte, P, Brissaud, J M, Delâge, Y, Drolet, E, Rioux
Publikováno v:
Cancer. 59(2)
Mean corpuscular volume (MCV) evolution during cytotoxic therapy was studied in 32 patients with Hodgkin's disease (HD) who developed therapy-related acute nonlymphocytic leukemia (t-ANLL) and in 64 HD controls matched for age, therapy duration, and
Autor:
J M, Delâge
Publikováno v:
Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles. 262(19)